MELOXICAM
| Brand name | VIVLODEX |
|---|---|
| Active ingredient | MELOXICAM |
| Strength | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** |
| Dosage form | CAPSULE |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | October 2015 |
| Marketing status | DISCN |
| Patent | Expires | Type |
|---|---|---|
| 9808468 | March 2035 | use U-2165 |
| 9649318 | March 2035 | product |
| 9526734 | March 2033 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.